39 Gribbestad I S, Nilsen G, Fjosne H E, et al. Comparitive signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging, 1994, 4: 477–480？？
[2]
1 American Cancer Society. Cancer Facts & Figures, 2009. Atlanta: American Cancer Society, Inc, 2009. 9–11
[3]
2 American Cancer Society. Breast Cancer Facts & Figures 2009-2010. Atlanta: American Cancer Society, Inc, 2009. 2–8
[4]
3 Kneeshaw P J, Lowry M, Manton D, et al. Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast-enhanced magnetic resonance imaging. Breast, 2006, 15: 29–38？？
[5]
4 Bazzocchi M, Zuiani C, Painizza P, et al. Contrast-enhanced breast MRI in patients with suspicious microcalcifiations on mammography: results of a multi-centre trial. AJR Am J Roentgenol, 2006, 186: 1723–1732？？
[6]
5 Hata T, Takahashi H, Watanabe K, et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasound. J Am Coll Surg, 2004, 198: 190–197？？
[7]
6 Pickles M D, Lowry M, Manton D J, et al. Role of dynamic contrast-enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat, 2005, 91: 1–10？？
[8]
7 Wasser K, Klein S K, Fink C, et al. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol, 2003, 13: 80–87
[9]
8 Padhani A R, Hayes C, Assersohn L, et al. Prediction of clinicopathological response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology, 2006, 239: 361–374？？
[10]
9 Fischer U, von Heyden D, Vosshenrich R, et al. Signal characteristics of benign and malignant breast lesionsin dynamic 2D-MRT of the breast. Rofo, 1993, 158: 287–292？？
[11]
10 Gibbs P, Liney G P, Lowry M, et al. Differentiation of benign and malignant sub-1cm breast lesions using dynamic contrast-enhanced MRI. Breast, 2004, 13: 115–121？？
[12]
11 Goto M, Ito H, Akazawa K, et al. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphological features. J Magn Reson Imaging, 2007, 25: 104–112？？
[13]
12 Kelcz F, Santyr G E, Cron G O, et al. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic contrast-enhanced MRI. J Magn Reson Imaging, 1996, 6: 743–752？？
[14]
13 Tofts P S, Kermode A G. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. Magn Reson Med, 1991, 17: 357–367？？
[15]
14 Tofts P S, Brix G, Buckley D L, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging, 1999, 10: 223–232？？
[16]
15 Hassid Y, Furman-Haran E, Margalit R, et al. Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors. Cancer Res, 2006, 66: 4159–4166？？
[17]
16 Reed R K, Rubin K. Transcapillary exchange: role and importance of the interstitial fluid pressure and the extracellular matrix. Cardiovasc Res, 2010, 87: 211–217？？
[18]
17 Abdullah N, Mesurolle B, El-Khoury M, et al. Breast imaging reporting and data system lexicon for US: interobserver agreement for assessment of breast masses. Radiology, 2009, 252: 665–672？？
[19]
18 Kuhl C K, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology, 1999, 211: 101–110
[20]
19 Szabo B K, Aspelin P, Wiberg M K, et al. Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria. Acta Radiol, 2003, 44: 379–386
[21]
20 Jansen S A, Fan X, Karczmar G S, et al. Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study. Magn Reson Med, 2008, 59: 747–754？？
[22]
21 Heiberg E V, Perman W H, Herrmann V M, et al. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magn Reson Imaging, 1996, 14: 337–348？？
[23]
22 Moate P J, Dougherty L, Schnall M D, et al. A modified logistic model to describe gadolinium kinetics in breast tumors. Magn Reson Imaging, 2004, 22: 467–473？？
[24]
23 Lagarias J C, Reeds J A, Wright M H, et al. Convergence properties of the nelder-mead simplex method in low dimensions. SIAM J Optimiz, 1998, 9: 112–147？？
[25]
24 Knopp M V, Weiss E, Sinn H P, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging, 1999, 10: 260–266？？
[26]
25 Kinkel K, Hylton N M. Challenges to interpretation of breast MRI. J Magn Reson Imaging, 2001, 13: 821–829？？
[27]
26 Bone B, Wiberg M K, Parrado C, et al. Mechanism of contrast enhancement in breast lesions at MR imaging. Acta Radiol, 1998, 39: 494–500
[28]
27 Buckley D L, Drew P J, Mussurakis S, et al. Microvessel density in invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging, 1997, 7: 461–464？？
[29]
28 Padhani A R. Dynamic contrast-enhanced MRI studies in human tumours. Br J Radiol, 1999, 72: 427–431
[30]
29 Parker G J, Suckling J, Tanner S F, et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging, 1997, 7: 564–574？？
[31]
30 Roberts H C, Roberts T P, Brasch R C, et al. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol, 2000, 21: 891–899
[32]
31 Donahue K M, Weisskoff R M, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging, 1997, 7: 102–110？？
[33]
32 Larsson H B, Rosenbaum S, Fritz-Hansen T. Quantification of the effect of water exchange in dynamic contrast MRI perfusion measurements in the brain and heart. Magn Reson Med, 2001, 46: 272–281？？
[34]
33 Buckley D L. Letter to the editor: transcytolemalWater Exchange and its effect on the determination of contrast agent concentration in vivo. Magn Reson Med, 2002, 47: 420–421？？
[35]
34 Calamante F, Morup M, Hansen L K. Defining a local arterial input function for perfusion MRI using independent component analysis. Magn Reson Med, 2004, 52: 789–797？？
[36]
35 Wang H N, Cui Y M, He H. A logistic model for magnetic energy storage in solar active regions. Res Astron Astrophys, 2009, 9: 687–693？？
[37]
36 Peleg M, Corradini M G, Normand M D. The logistic (Verhulst) model for sigmoid microbial growth curves revisited. Food Res Int, 2007, 40: 808–818？？
[38]
37 Sakuma Y, Okamoto N. A logistic regression predictive model and the outcome of patients with resected lung adenocarcinoma of 2 cm or less in size. Lung Cancer, 2009, 65: 85–90？？
[39]
38 Mussarakis S, Buckley D L, Horsman A. Dynamic MRI of invasive breast cancer: assessment of three region-of-interest analysis methods. J Comput Assist Tomogr, 1997, 21: 431?438？？
